Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Adverse events in phase-I studies: a report in 1015 healthy volunteers.

Sibille M, Deigat N, Janin A, Kirkesseli S, Durand DV.

Eur J Clin Pharmacol. 1998 Mar;54(1):13-20.

PMID:
9591924
[PubMed - indexed for MEDLINE]
2.

Adverse events in volunteers participating in phase I clinical trials: a single-center five-year survey in 1,559 subjects.

Lutfullin A, Kuhlmann J, Wensing G.

Int J Clin Pharmacol Ther. 2005 May;43(5):217-26.

PMID:
15906587
[PubMed - indexed for MEDLINE]
3.

Adverse events in phase one studies: a study in 430 healthy volunteers.

Sibille M, Deigat N, Olagnier V, Durand DV, Levrat R.

Eur J Clin Pharmacol. 1992;42(4):389-93.

PMID:
1516603
[PubMed - indexed for MEDLINE]
4.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
5.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
[PubMed - indexed for MEDLINE]
6.

Critical limits to define a lab adverse event during phase I studies: a study in 1134 subjects.

Sibille M, Bresson V, Janin A, Boutouyrie B, Rey J, Vital Durand D.

Eur J Clin Pharmacol. 1997;52(2):81-6.

PMID:
9174675
[PubMed - indexed for MEDLINE]
7.

Adverse events and discomfort in studies on healthy subjects: the volunteer's perspective. A survey conducted by the German Association for Applied Human Pharmacology.

Hermann R, Heger-Mahn D, Mahler M, Seibert-Grafe M, Klipping C, Breithaupt-Grögler K, de Mey C.

Eur J Clin Pharmacol. 1997;53(3-4):207-14.

PMID:
9476033
[PubMed - indexed for MEDLINE]
8.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
[PubMed - indexed for MEDLINE]
9.

The placebo effect in healthy volunteers: influence of experimental conditions on the adverse events profile during phase I studies.

Rosenzweig P, Brohier S, Zipfel A.

Clin Pharmacol Ther. 1993 Nov;54(5):578-83.

PMID:
8222500
[PubMed - indexed for MEDLINE]
10.
11.

Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.

Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.

CNS Drugs. 2003;17(9):653-67.

PMID:
12828501
[PubMed - indexed for MEDLINE]
12.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
[PubMed - indexed for MEDLINE]
13.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
14.

Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.

Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.

CNS Drugs. 2003;17(11):839-51.

PMID:
12921494
[PubMed - indexed for MEDLINE]
15.

Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.

Mannix LK, Savani N, Landy S, Valade D, Shackelford S, Ames MH, Jones MW.

Headache. 2007 Jul-Aug;47(7):1037-49.

PMID:
17635595
[PubMed - indexed for MEDLINE]
16.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
[PubMed - indexed for MEDLINE]
17.

Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.

Smith WB, Dowell JA, Pratt RD.

Clin Ther. 2007 Jul;29(7):1368-80.

PMID:
17825688
[PubMed - indexed for MEDLINE]
18.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

PMID:
15842952
[PubMed - indexed for MEDLINE]
Free Article
19.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
[PubMed - indexed for MEDLINE]
20.

The safety of healthy volunteers in First-in-Man trials - an analysis of studies conducted at the Bayer in-house ward from 2000 to 2005.

Wensing G, Ighrayeb IA, Boix O, Böttcher M.

Int J Clin Pharmacol Ther. 2010 Sep;48(9):563-70.

PMID:
20860909
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk